Abstract. ATX-s10-Na(II) is a novel second-generation photo-sensitizer for photodynamic therapy (PDT). PDT using ATX-s10 and diode laser (670 nm) induces an apoptotic response, inflammatory reaction, immune reaction and damage to the microvasculature. In particular, the vascular shut-down effect plays an important role in the anti-tumor activity of ATX-s10-
Introduction
Photodynamic therapy (PDT), one of the treatment modalities for cancer, uses a photosensitizer and laser irradiation to induce the production of reactive oxygen species in cancer cells (1) (2) (3) (4) . In Japan, the US, and many other countries, PDT is widely used as a treatment option for solid cancers (5, 6) . Since the first modern clinical trial of PDT reported in 1978 by Dougherty et al (7) , PDT using photosensitizer, Photofrin (porfimer sodium), has been applied to many cancer types and is approved by the US Food and Drug Administration for the treatment of advanced esophageal cancer as well as early-stage and advanced-stage lung cancers (8, 9) . In order to enhance the efficacy of PDT and expand its clinical applications, a variety of second-generation photosensitizers are now being assessed for their efficacy in cancer therapy (4, 10, 11) .
ATX-s10 is a second generation photosensitizer containing hydrophilic chlorine with a maximum absorption at 670 nm, which can penetrate deeper than Photofrin, which has a maximum absorption wavelength of 630 nm (12) (13) (14) . It has been reported that PDT using ATX-s10 and a diode laser has a strong anti-tumor effect and induces congestion and thrombus formation in tumor vessels, with degeneration of the tumor vascular endothelial cells (12, 13) . Masumoto et al reported that in particular, a vascular shut-down effect plays an important role in the anti-tumor activity of PDT using ATX-s10 (14) . Recently, we have reported that lysosomal damage by PDT using ATX-s10 can initiate apoptotic response and this apoptotic pathway can be regulated by photodamage to Bcl-2 via mitochondrial damage (15) . However, the precise mechanism of the anti-tumor effect of ATX-s10-PDT has not yet been elucidated.
Most photosensitizers, such as Photofrin, ATX-s10, phthalocyanine 4 (Pc 4), preferentially bind to mitochondrial membranes, endoplasmic reticulum, and Golgi complexes in cancer cells, but do not accumulate in cell nuclei (2, 3, 15) . It has been reported that PDT rapidly induce apoptosis, inflammatory reaction, tumor-specific and/or -nonspecific ONCOLOGY REPORTS 18: 679-683, 2007 
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A possible relationship between the anti-cancer potency of photodynamic therapy using the novel photosensitizer ATX-s10-Na(II) and expression of the vascular endothelial growth factor in vivo (20) . In this study, in order to elucidate the precise mechanism of action of ATX-s10-PDT, we examined whether the increase of expression of VEGF caused by ATX-s10 via microvasculature damage could lead to recurrence, using VEGF secreting lung cancer in vivo.
Materials and methods
Cell culture. Human lung cancer cell line, SBC-3 was established at Department of Medicine, Okayama University school of Medicine (Okayama, Japan). SBC-3/VEGF cells were established at Pharmacology Division, National Cancer Center Research Institute (21, 22) . SBC-3 cells and SBC-3/ VEGF cells were cultured in RPMI-1640 containing 10% fetal bovine serum at 37˚C in humidified air containing 5% CO 2 .
Mice. Female Balb/c-nu/nu nude mice, 5 weeks old were purchased from Japan Charles River Co., Ltd. (Atsugi, Japan) (21, 22) . These mice were maintained under specific pathogenfree conditions in our university animal facility.
cDNA microarray analysis. Gene expressions in lung cancer cells, SBC-3 cells before PDT or 3 h after PDT, were analyzed using a cDNA microarray. We performed PDT for SBC-3 cells at LD 90 (8.0 μg/ml ATX-s10, 10 J/cm 2 laser irradiation) dose and extract mRNA and purified using total RNA kit (Qiagen, Hilden, Gemany). RNA was reverse-transcribed in the presence of [α-32 p]dATP using the Atlas Pure Total RNA labeling system (Clontech, Palo Alto, CA, USA). We used a commercially available cDNA microarray, the Atlas Human 1.2 array (Clontech), on which 1176 cancer-related gene fragments had been arrayed. Information about genes on the microarray can be obtained from URL; http://atlas.info. clontech.com. Hybridization of the 32 p-labeled cDNA with the array with the array membrane was performed according to the manufacturer's instructions. The membrane was analyzed by an imaging analyzer (BAS2000; Fuji Photo Film, Tokyo, Japan) and the hybridization signals were quantified by the ArrayGauge version 1.2 software. Gene expression was quantified as the tumor-to-normal fluorescence ration (T:N ratio) (23, 24) . The gene was overexpressed at ≥2 and underexpressed when the ration was <0.5.
Photosensitizer. ATX-s10Na (II) (13,17-bis-1 carboxypropionyll carba-Moylethyl-8-e-thenyl-2-hydroxy-3-hydroxyimino-ethylidene-2,7,12,18-tetramethyl porphyrin sodium; molecular weight, 927.79) was supplied by the Photochemical Co. Ltd. (Okayama, Japan) (12) (13) (14) (15) . This photosensitizer has the highest absorption peak at 670 nm (12-15). ATX-s10 was stored as powder in the dark. The ATX-s10 powder was dissolved in phosphate-buffered saline (PBS) (Invitrogen, CA, USA).
Laser unit. A diode laser (LD670-05; Hamamatsu Photonics K.K., Hamamatsu, Japan) emitting continuous-wave laser light at a wavelength of 670 nm was the light source for excitation of ATX-s10 (12) (13) (14) (15) .
Clonogenic cell survival. Cells were collected from the monolayer with trypsin immediately after ATX-s10-PDT. Aliquots of the cells were seeded into 25 cm 2 flasks in amounts sufficient to yield 50-150 colonies. After incubation for 10-14 days, the cells were stained with 0.1% crystal violet in 20% ethanol, and colonies containing at least 50 cells were counted (15, 25) . The plating efficiency of untreated cells was 30-40%.
In vivo treatment protocols. SBC-3 cells and SBC-3/VEGF cells were harvested during the exponential growth phase.
Cells were washed twice in Hank's solution (Invitrogen) and 10 7 cells were inoculated subcutaneously into the right thigh of nude mice (19) (20) (21) . The lesions reached 6-7 mm in diameter and then the transplanted tumors were treated by ATX-s10-PDT. Three hours after ATX-x10 (5 mg/kg) was intravenously administered; the tumors were irradiated by 200 J/cm 2 dose of 670-nm light. After ATX-s10-PDT, mice were monitored for tumor recurrences 3 times per week for 24 days. Tumor volumes were calculated using the following formula: Tumor ONCOLOGY REPORTS 18: 679-683, 2007 Table I . Gene expression in SBC-3 cells following ATX-s10-PDT. 
-----------------------------------------------------------------------------------------------------Gene GenBank # Up Down -----------------------------------------------------------------------------------------------------
2 /2 (L, long diameter; D, short diameter). Tumor volumes >1000 mm 3 were recorded and judged as recurrence (19) (20) (21) 26) .
Results and Discussion
Using a microarray analysis 11 overexpressed genes (T:N ratio >2.0) and 13 underexpressed genes were identified following ATX-s10-PDT at LD 90 dose (8 μg/ml ATX-s10, 10 J/cm 2 laser irradiation). In cell cycle related genes, mRNA of SMAD4, p21 CIP1 , CDC-like kinase (CLK-1) genes were induced 3 h after PDT (Table I ). In particular, the induction of p21 CIP1 can be an important factor as an apoptotic response as we previously reported that ATX-s10-PDT caused morphologically typical apoptosis (15) . Although photosensitizer ATX-s10 does not accumulate in cell nuclei and the potential of PDT to cause DNA damage, mutations, and carcinogenesis is low, Table I shows that DNA damage-inducible genes (GADD-153, GADD-45) were highly overexpressed after PDT. GADD-153 (CHOP) was originally identified as a growth arrest and DNA damage-inducible gene (27) , and Wong et al reported that it was identified as a highly overexpressed gene following Photofrin-PDT (28) . GADD-153 is also an endoplasmic reticulum (ER) stress inducible transcription factor involved in the development of apoptosis. These data suggest that ATX-s10-PDT can damage ER membrane as we previously reported that ATX-s10 localized to mitochondria, lysosomal, ER and other intracellular organelles (15) .
It has been reported that PDT rapidly induces inflammatory reaction, tumor-specific and/or -nonspecific immune reaction (2, 4, 15, 16, 29) . We previously reported that TNF-α, IL-2, IL-6 were induced by NPe6-PDT (16) . In this study, PDT using ATX-s10 induced VEGF, IL-6, and endothelial plasminogen activator inhibitor-1 (Table I) . It is unclear whether the expression of VEGF may be a determinant factor of antitumor activity of ATX-s10-PDT in vitro. We evaluated the sensitivity of SBC-3/VEGF cells, which overexpress vascular endothelial growth factor, against ATX-s10-PDT by clonogenic assay (Fig. 1) . The survival curves indicate that there was no significant difference of the anti-tumor effect between in SBC-3/VEGF and parent SBC-3 cells (Fig. 1) . This result suggests that VEGF expression does not exert a marked regulatory effect on cell survival of ATX-s10-PDT in vitro. However, Masumoto et al reported that a vascular shut-down effect played an important role in the anti-tumor activity of ATX-s10-PDT (14) . With some photosensitizers, the effect on the vasculature is the most important mechanism of the therapeutic effect by PDT. Gomer et al reported that Photofrin-PDT induced expression of HIF-1α and VEGF in tumors (11) , and that tumor-bearing mice treated with a combination of Photofrin-PDT and non-specific antiangiogenetic agents improved anti-tumor effect as measured by increased time to recurrence and increased cures (11, 20, 26) . We hypothesized that ATX-s10-PDT may attribute its failure as recurrence to the induction of expression of VEGF following the damage of microvasculature and hypoxic change in the tumors. Jiang et al demonstrated that by immunohistological study, VEGF expression increased within the PDT-treated lesion one week after Photofrin-PDT and remained elevated for a few weeks, and they suggested that tumor recurrence after PDT may be regulated by the enhancement of VEGF expression and angiogenesis within the treated area (30) .
However, as Fig. 2 shows, there was no statistical difference of the anti-tumor effect as measured by tumor cures between SBC-3 tumors and SBC-3/VEGF tumors in vivo. These data suggest that ATX-s10-PDT has anti-tumor effect depending upon expression of VEGF and a unique tumoricidal action. In conclusion, ATX-s10-PDT may prevent tumor recurrence in spite of induction of VEGF and promotion of tumor angiogenesis, which are known to enhance tumor proliferation and survival.
